Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease ProgressionPhyllis Kanki, Souleymane Mboup|The Journal of Infectious Diseases|1999Cited by 381
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Mark Thursz, Louise Sarr et al.|The Lancet Global Health|2016Cited by 182
Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolutionMarco Salemi, Anne–Mieke Vandamme, Korbinian Strimmer et al.|The FASEB Journal|2000Cited by 172
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programmeAmina Sow, Souleymane Mboup, Maud Lemoine et al.|JHEP Reports|2022Cited by 22
Implementation of an in‐house quantitative real‐time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS. Monty Ghosh, Isabelle Chemin, A. Sow et al.|Journal of Viral Hepatitis|2016Cited by 19